A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Setting and Design
2.2. Recruitment and Participants
2.3. Population Sample
2.4. Data Collection
2.5. Qualitative Analysis
3. Results
3.1. Misinformation or Misconceptions about COVID-19 Vaccines
“Research side in terms of the vaccine being a newer technology that a lot of people don’t understand again because of…the abysmal scientific literacy of our society as a whole and, it becomes really easy to latch on to things,” Non-medical health professional.
“Sometimes, that context was missing. It was just presented as the Holy Grail, or the truth,” Medical professional.
“You know, there’s a lot of information on where…news is often not that accurate,” Medical professional.
“They didn’t really help me, like the news and stuff,” Caregiver.
“Due to some sort of misconception about the risks associated with vaccines,” ND individuals.
3.2. Perception of Vaccine Risk and Mistrust in Medical Institutions
“[Patients] heard that somebody they know [had a] really bad reaction to the second dose, and now they’re extra nervous about it,” Medical professional.
“[People are] afraid that if they do take [the vaccine] they’re going to get sick,” Caregiver.
“There are a lot of scary stories out there about potential negative effects of vaccines,” Caregiver and medical professional.
“There’s just a subset of people out there that have these phobias, they might have had a bad experience,” Medical professional.
3.3. Mental Health Challenges and Sensory Sensitivities
“So, for kids, for example, who might be afraid of vaccines or maybe have needle phobia,” Medical professional.
“Individuals with neurodevelopmental disabilities may have sensory concerns, and so because the vaccination involves a needle that does puncture the skin. And on top of the anxiety of neurosensory issues this population may have increased challenges with receiving a vaccination or getting blood drawn,” Medical professional.
“You know, health care, anxieties, and even coming to the clinic, may be a little bit anxiety provoking for them… I think during a pandemic, where they can perceive it’s like ‘Oh, what if I catch an infection, if I you know, go to the clinic?’” Medical professional.
3.4. Other Barriers: Structural Barriers and Lack of Awareness
“Some of it is like the even like this room that I’m in right it’s not built for anybody with a wheelchair,” Medical professional.
“It’s having the Kroger pharmacy, or having the CVS and the Walgreens, which right now all have the signs up saying walk in, you know, COVID vaccinations are available, the problem is you got to be able to get to that location to walk in, and they’re all more than two miles away from most people’s home,” Medical professional.
“But I think we’ve seen some more barriers in terms of actually getting them into the clinic to do the vaccines,” Medical professional.
“I had a patient the other day that said no, I’ve been sick for the last three months and I haven’t been able to drive, and I don’t have a ride,” Medical professional and caregiver.
3.5. Facilitators to Vaccine Confidence
“I always mentioned that we like to follow the CDC vaccine guidelines and recommendations,” Medical professional.
“I refer them to go back to the CDC,” Non-medical health professional.
“I’ve been providing evidence-based resources,” Medical professional.
“[The] CDC started helping a little bit and made me more confident,” Caregiver.
“I think that actually showing like real data, or a subset of data, that sort of boil down is good,” ND-identifying physician in training.
“Give as much information and as clear of a way that you could, so that parents would be more likely to get it,” ND caregiver.
“A lot of people with special needs, they go by pictures, not just words, they want pictures, they want simple language,” ND caregiver.
“I recommend their primary care because at the end of the day that’s their central person,” Non-medical health professional.
“I think one of the best things now…. is that things have kind of trickled down to individual providers with their specific patients,” Medical professional.
3.6. Suggestions for Improving Vaccine Confidence
“Rich, full conversation and that openness is really important, and many people, I think, who initially [are hesitant],” Non-medical Health Professional.
“You know, [it] makes a big difference to being able to … Say, ‘Hey, Tell me your concerns. Tell me what your questions are.’ Let’s try to see what we can do to answer those questions,” Medical professional.
“Scheduling those patients for a little bit of extra time, maybe doing that prep work ahead of time,” Medical professional.
“A typically shot [is] like 10 min or 15 min. You might consider extending that time for someone who is more anxious,” Medical professional.
“Also just…advocating for either yourself as the patient or for the patient if you’re a parent,” Medical professional.
“I think we really need to get into the community and do more work internally from inside out, as opposed to top down,” Social worker.
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A. Sample Interview Guide for Physician Interviewee
UCLA COVID-19 Vaccine Confidence Project Logistical Information [REDACTED] Introduction Interviewee biography: [REDACTED] Brief Project Summary: We are interviewing you to discuss the Needle Anxiety Program at UCLA to learn about the program and what you have learned about needle anxiety in the neurodivergent & disability community during the COVID-19 pandemic. We are specifically interested in your perspective as a physician working on the Needle Anxiety Program and what we can learn from the program as we try to increase vaccine confidence in the disability community. |
Questions Needle Anxiety Program
|
Appendix B. Sample Interview Guide for Physician Interviewee
UCLA COVID-19 Vaccine Confidence Project Interview Guide for [REDACTED] Are you okay with this interview being recorded? Logistical Information [REDACTED] |
Brief Project Summary: The goal of the project is to help promote vaccine confidence in the disability community. We are particularly interested in your perspective as a scientist and expert in scientific dissemination. |
Questions
|
References
- Gleason, J.; Ross, W.; Fossi, A.; Blonsky, H.; Tobias, J.; Stephens, M. The Devastating Impact of COVID-19 on Individuals with Intellectual Disabilities in the United States. N. Engl. J. Med. 2021, 2, 1–12. [Google Scholar] [CrossRef]
- Shah, P.J.; Boilson, M.; Rutherford, M.; Prior, S.; Johnston, L.; Maciver, D.; Forsyth, K. Neurodevelopmental Disorders and Neurodiversity: Definition of Terms from Scotland’s National Autism Implementation Team. Br. J. Psychiatry 2022, 221, 577–579. [Google Scholar] [CrossRef] [PubMed]
- Iadarola, S.; Siegel, J.F.; Gao, Q.; McGrath, K.; Bonuck, K.A. COVID-19 Vaccine Perceptions in New York State’s Intellectual and Developmental Disabilities Community. Disabil. Health J. 2022, 15, 101178. [Google Scholar] [CrossRef] [PubMed]
- Landes, S.D.; Turk, M.A.; Formica, M.K.; McDonald, K.E.; Stevens, J.D. COVID-19 Outcomes among People with Intellectual and Developmental Disability Living in Residential Group Homes in New York State. Disabil. Health J. 2020, 13, 100969. [Google Scholar] [CrossRef] [PubMed]
- Nonweiler, J.; Rattray, F.; Baulcomb, J.; Happé, F.; Absoud, M. Prevalence and Associated Factors of Emotional and Behavioural Difficulties during COVID-19 Pandemic in Children with Neurodevelopmental Disorders. Children 2020, 7, 128. [Google Scholar] [CrossRef]
- Pujolar, G.; Oliver-Anglès, A.; Vargas, I.; Vázquez, M.-L. Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review. Int. J. Environ. Res. Public Health 2022, 19, 1749. [Google Scholar] [CrossRef]
- Saline, S. Thriving in the New Normal: How COVID-19 Has Affected Alternative Learners and Their Families and Implementing Effective, Creative Therapeutic Interventions. Smith Coll. Stud. Soc. Work 2021, 91, 1–28. [Google Scholar] [CrossRef]
- Cassidy, S.A.; Nicolaidis, C.; Davies, B.; Rosa, S.D.R.; Eisenman, D.; Giwa Onaiwu, M.; Kapp, S.K.; Kripke, C.C.; Rodgers, J.; Waisman, T. An Expert Discussion on Autism in the COVID-19 Pandemic. Autism Adulthood 2020, 2, 106–117. [Google Scholar] [CrossRef]
- Hildreth, J.E.K.; Alcendor, D.J. Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity. Vaccines 2021, 9, 489. [Google Scholar] [CrossRef]
- Shea, L.L.; Becker, A.; Lee, B.K.; Miller, K.K.; Cooper, D.; Anderson, K.; Salzer, M.S.; Vanness, D.J. Self-Reported COVID-19 Vaccination Acceptance and Hesitancy among Autistic Adults. Vaccine 2022, 40, 3288–3293. [Google Scholar] [CrossRef]
- Thorpe, A.; Fagerlin, A.; Drews, F.A.; Butler, J.; Stevens, V.; Riddoch, M.S.; Scherer, L.D. Communications to Promote Interest and Confidence in COVID-19 Vaccines. Am. J. Health Promot. 2022, 36, 976–986. [Google Scholar] [CrossRef]
- Bonsu, N.E.M.; Mire, S.S.; Sahni, L.C.; Berry, L.N.; Dowell, L.R.; Minard, C.G.; Cunningham, R.M.; Boom, J.A.; Voigt, R.G.; Goin-Kochel, R.P. Understanding Vaccine Hesitancy among Parents of Children with Autism Spectrum Disorder and Parents of Children with Non-Autism Developmental Delays. J. Child Neurol. 2021, 36, 911–918. [Google Scholar] [CrossRef] [PubMed]
- Weinstein, O.; Krieger, I.; Cohen, A.D.; Tzur Bitan, D. COVID-19 Vaccination among Individuals with Autism Spectrum Disorder: A Population-Based Study. Res. Autism Spectr. Disord. 2021, 89, 101865. [Google Scholar] [CrossRef] [PubMed]
- Kirzinger, A.; Sparks, G.; Hamel, L.; Lopes, L.; Kearney, A. KFF COVID-19 Vaccine Monitor: July 2021. Available online: https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-july-2021 (accessed on 6 March 2023).
- Hotez, E.; Hotez, P.J.; Rosenau, K.A.; Kuo, A.A. Prioritizing COVID-19 Vaccinations for Individuals with Intellectual and Developmental Disabilities. eClinicalMedicine 2021, 32, 100749. [Google Scholar] [CrossRef] [PubMed]
- Yoon, W.-H. Why Fast COVID-19 Vaccination Needed for People with Disabilities and Autistics in Korea? J. Korean Med. Sci. 2021, 36, e267. [Google Scholar] [CrossRef]
- Lugo-Agudelo, L.; Spir Brunal, M.A.; Posada Borrero, A.M.; Cruz Sarmiento, K.M.; Velasquez Correa, J.C.; Di Dio Castagna Iannini, R.; Gonzalez Zuluaga, M.; Ospina, V.A.; Patiño Lugo, D.F.; Mesa Franco, L.F.; et al. Countries Response for People with Disabilities during the COVID-19 Pandemic. Front. Rehabil. Sci. 2022, 2, 796074. [Google Scholar] [CrossRef]
- Krieger, I.; Erez, G.; Weinstein, O.; Cohen, A.D.; Tzur Bitan, D. COVID-19 Morbidity among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study. J. Autism Dev. Disord. 2023, 53, 789–794. [Google Scholar] [CrossRef]
- Turk, M.A.; Landes, S.D.; Formica, M.K.; Goss, K.D. Intellectual and Developmental Disability and COVID-19 Case-Fatality Trends: TriNetX Analysis. Disabil. Health J. 2020, 13, 100942. [Google Scholar] [CrossRef]
- Alderotti, G.; Corvo, M.F.; Buscemi, P.; Stacchini, L.; Giorgetti, D.; Lorini, C.; Bonaccorsi, G.; Pinilla, M.J.C.; Lastrucci, V. Communicating with Patients about COVID-19 Vaccination: A Qualitative Study on Vaccinators in Tuscany Region, Italy. Vaccines 2023, 11, 223. [Google Scholar] [CrossRef] [PubMed]
- Schmitt, H.-J.; Booy, R.; Aston, R.; Van Damme, P.; Schumacher, R.F.; Campins, M.; Rodrigo, C.; Heikkinen, T.; Weil-Olivier, C.; Finn, A.; et al. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med. 2007, 5, 11. [Google Scholar] [CrossRef]
- Denford, S.; Mowbray, F.; Towler, L.; Wehling, H.; Lasseter, G.; Amlôt, R.; Oliver, I.; Yardley, L.; Hickman, M. Exploration of Attitudes Regarding Uptake of COVID-19 Vaccines among Vaccine Hesitant Adults in the UK: A Qualitative Analysis. BMC Infect. Dis. 2022, 22, 407. [Google Scholar] [CrossRef]
- Hotez, E.; Gragnani, C.M.; Fernandes, P.; Rosenau, K.A.; Wang, K.; Chopra, A.; Chow, K.; Chung, A.; Khorasani, L.; Kuo, A.A. A Mixed Methods Investigation of College Student Mental Health during the First Year of the COVID-19 Pandemic. J. Am. Coll. Health 2022, 1–8. [Google Scholar] [CrossRef]
- Miller, L.; Reynolds, J. Autism and Vaccination-The Current Evidence. J. Spec. Pediatr. Nurs. 2009, 14, 166–172. [Google Scholar] [CrossRef] [PubMed]
- Soares, P.; Rocha, J.V.; Moniz, M.; Gama, A.; Laires, P.A.; Pedro, A.R.; Dias, S.; Leite, A.; Nunes, C. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines 2021, 9, 300. [Google Scholar] [CrossRef]
- Troiano, G.; Nardi, A. Vaccine Hesitancy in the Era of COVID-19. Public Health 2021, 194, 245–251. [Google Scholar] [CrossRef] [PubMed]
- McNeil, A.; Purdon, C. Anxiety Disorders, COVID-19 Fear, and Vaccine Hesitancy. J. Anxiety Disord. 2022, 90, 102598. [Google Scholar] [CrossRef]
- Aw, J.; Seng, J.J.B.; Seah, S.S.Y.; Low, L.L. Covid-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries. Vaccines 2021, 9, 900. [Google Scholar] [CrossRef]
- Love, A.S.; Love, R.J. Considering Needle Phobia among Adult Patients during Mass COVID-19 Vaccinations. J. Prim. Care Community Health 2021, 12, 1–4. [Google Scholar] [CrossRef]
- Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef]
- Richman, W.L.; Kiesler, S.; Weisband, S.; Drasgow, F. A meta-analytic study of social desirability distortion in computer-administered questionnaires, traditional questionnaires, and interviews. J. Appl. Psychol. 1999, 84, 754–775. [Google Scholar] [CrossRef]
Field | Position | Number |
---|---|---|
Healthcare | Physician | 7 |
Nurse | 1 | |
Social Worker | 1 | |
Physician in Training | 2 | |
Academia | Science Faculty (Non-Medical Health Professional) | 6 |
Lived Experience | Caregiver * | 3 |
ND Individual | 2 |
Code | Operational Definition | Example Quotations | % Frequency | Occurrence |
---|---|---|---|---|
Lack of awareness | Lack of awareness of programs that support vaccination efforts | “I think there’s a lot of people who aren’t aware of the service that we offer at the needle anxiety program.” —Medical professional | 37.50% | 6 |
Misinformation | General misinformation or misconception perceived by people | “It can be really scary sometimes because of the conviction of which some people believe fantastical things.” —Non-medical health professional | 81.25% | 13 |
Mistrust in medical system/personal/community experiences | Mistrust or phobia that prevents vaccination either due to historical discrimination or past experiences with the medical system | “In medical settings, if you’ve been in that situation where you’ve never been heard, or where someone told you ‘We’re going to one thing,’ but really, they do something else to you quickly, you know that’s what will stay with you.” —Medical professional | 43.75% | 7 |
Perception of vaccination risk | Any perception that vaccines pose a risk to their health. Could be due to misinformation or misconception | “There is a fear of getting an illness that you can prevent with a vaccine or fear of getting a vaccine that may have unknown side effects.” —Medical professional and caregiver | 56.25% | 9 |
Mental health/sensory sensitivities or other activities | Mental health or sensory sensitivities that prevent people from receiving vaccines or adhering to COVID-19 protocols | “Individuals with neurodevelopmental disabilities may have sensory concerns, especially with vaccination involving a needle that punctures the skin leading to increased challenges with receiving vaccination.” —Medical professional | 87.50% | 14 |
Structural/socioeconomic barriers | Structural barriers that prevent people from receiving vaccines | “Those are also the same neighborhoods where people don’t have independent vehicles… they’re quite dependent upon bus lines and the bus lines are mediocre at best.” —Social worker | 37.50% | 6 |
Code | Operational Definition | Example Quotation | % Frequency | Occurrence |
---|---|---|---|---|
Community-based strategies | Community-targeted strategies that facilitate COVID-19 vaccination or vaccine confidence | “Our regional center [sent] some emails and phone calls along the way [that the patient is too young and not yet eligible for a vaccine for.” —Caregiver and medical professional | 37.50% | 6 |
Knowledge and information dissemination | Information that is disseminated regarding COVID-19 broadly or the vaccine that helps people to understand and receive vaccination | “Information [was] disseminated about [how] even though [the vaccine] came out very quickly, it was decades in the making, and that this technology has been [thoroughly] worked on and developed.” —Medical professional | 50.00% | 8 |
Targeted social media campaigns | Modes for targeted social media campaigns that have been successful in facilitating vaccine confidence | “[We use] different voices or different styles [depending on] the nature of the audience and it’s been really helpful for us to make new connections.” —Non-medical health professional | 18.75% | 3 |
Perceived importance of vaccination | Perception that vaccination is good for themselves, family, and society | “It was very reassuring that at some point she will also be protected from something that could be significantly more dangerous for her than her siblings.” —Caregiver and medical professional | 37.50% | 6 |
Providing medical accommodations | Medical therapies or treatment used as accommodations for the general public or neurodivergent community | “We can administer between 5 to 10 milligrams of sedation [for needle anxiety].” —Medical professional | 31.25% | 5 |
Providing non-medical accommodations | Non-medical accommodations provided to the general public or neurodivergent community | “Whatever is going to help calm [the patient can help with the vaccination process]. Some distractions might be something a buzzer or videos.” —Medical professional | 31.25% | 5 |
Current public health/vaccine policies and programs | Broad public health vaccination programs or policies that make it easier for people to get vaccination | “Decreasing the anxiety around a procedure that involves needles would help everyone with this concern and not just disabled populations.” —Medical professional | 25.00% | 4 |
Experience or relationship with a health care professional | Interpersonal relationship or experience with healthcare professional that facilitates vaccine confidence | “Doctors talk to their patients about needle anxiety program, so their [positive] experience with the doctor allows them to get the vaccine in a way that’s comfortable.” —Medical professional | 37.50% | 6 |
Sources of information | Broader sources of credible public health information and news used by experts | “Folks must be cautious with where they are getting their information and ensure that they are validated sites that are scientific.” —Non-medical health professional | 56.25% | 9 |
Subjective norm | Seeking normalcy or following perception of what others believe is right | “I sense a large decision maker for a lot of people is wanting to get to a life of some degree of normalcy.” —Caregiver and medical professional | 25.00% | 4 |
Code | Operational Definition | Example Quotation | % Frequency | Occurrence |
---|---|---|---|---|
Bridging gaps in knowledge of vaccine | Ways to improve transparency and information dissemination between scientific community and general public | “Initially we focused on making sure people understood what a vaccine is and that it’s not like a magic bubble.” —Non-medical health professional | 18.75% | 3 |
Public health/vaccine policies and programs suggestions | Public health vaccination programs or policies that make it easier for people to receive vaccination and that are widely applied | “A targeted approach and maybe increasing resources in some of those areas where the families just aren’t really going to be able to access things or advocate for things on their own.” —Social worker | 18.75% | 3 |
Suggestions for future research | Future research ideas or suggestions | “I think that we should have additional studies to that should be conducted on vaccines for different populations.” | 12.50% | 2 |
Suggestions for families and caregivers | Ways families can help themselves or their community become more confident in the COVID-19 vaccine | “Family members who bring in the patient are also a source of support and calm and understands exactly what’s going to happen and is well coordinated, [this] reduces the patient’s anxiety.” —Medical Professional | 50.00% | 8 |
Communication | Suggestions for improving patient–provider communication | “I’d say the most important thing is nobody likes surprises. The more we can explain up front, maybe you walk through the scenario, talk through how it’s going to go, the smoother things will go.” —Medical Professional | 75.00% | 12 |
Medical/epidemiology knowledge | Suggestions for health care providers to improve their own medical knowledge (re: vaccinations) | “So, what [colleague physician] did is she went and downloaded all the articles. Now, she wasn’t saying to the patients that they need to go read all those articles. She’s basically saying, I know how to read all those articles. And I read them all and I can tell you about it.” —Non-medical health professional | 12.50% | 2 |
Training | Recommendation for improving the training of health care professionals and students in training | “We have implemented some training to have our medical assistants take a smidgeon longer with some of these anxious patients because maybe that’s all they need.” —Medical professional | 31.25% | 5 |
Accommodations designed to remove of structural barriers to vaccination access | Accommodations to alleviate structural or socioeconomic barriers that prevent people from receiving vaccines | “So, you’re being thoughtful that you know, this needs to be addressed and maybe revisit periodically to check in is important, maybe scheduling those patients are a little bit of extra time, maybe doing that prep work ahead of time during email or something like that.” —Medical professional | 50.00% | 8 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Khorasani, L.N.; Bastani, A.; Shen, T.; Kaur, G.; Shah, N.D.; Juarez, L.; Heyman, M.; Grassian, J.; Cho, A.-C.; Hotez, E. A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines 2023, 11, 895. https://doi.org/10.3390/vaccines11050895
Khorasani LN, Bastani A, Shen T, Kaur G, Shah ND, Juarez L, Heyman M, Grassian J, Cho A-C, Hotez E. A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines. 2023; 11(5):895. https://doi.org/10.3390/vaccines11050895
Chicago/Turabian StyleKhorasani, Laila N., Asal Bastani, Tammy Shen, Gurlovellen Kaur, Nilpa D. Shah, Lucia Juarez, Michelle Heyman, Julie Grassian, An-Chuen Cho, and Emily Hotez. 2023. "A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities" Vaccines 11, no. 5: 895. https://doi.org/10.3390/vaccines11050895
APA StyleKhorasani, L. N., Bastani, A., Shen, T., Kaur, G., Shah, N. D., Juarez, L., Heyman, M., Grassian, J., Cho, A. -C., & Hotez, E. (2023). A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines, 11(5), 895. https://doi.org/10.3390/vaccines11050895